Taken together, these results provide evidence that lack of caspase 8 expression is an inherent feature of the majority of human SCLC and recapitulation of this feature in a genetically engineered mouse model reveals that it serves progression to metastatic disease. The gene discussed is CASP8; the disease is small cell lung carcinoma.